Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Phase 1

Terminated

Conditions: Adult Anaplastic Astrocytoma
Adult Anaplastic Ependymoma
Adult Anaplastic Oligodendroglioma
Adult Brain Stem Glioma
Adult Central Nervous System Germ Cell Tumor
Adult Choroid Plexus Tumor
Adult Craniopharyngioma
Adult Diffuse Astrocytoma
Adult Ependymoblastoma
Adult Ependymoma

Interventions: Procedure: conventional surgery
Drug: EF5
Procedure: positron emission tomography
Radiation: fluorine F 18 EF5
Other: pharmacological study

First Posted Date: 2005-05-04

Last Posted Date: 2013-01-16

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 46

Registration Number: NCT00110032

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluation of Diabetes Self-Management Consultant Care

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: Diabetes Self-Management Consultant
Behavioral: Enhanced Usual Care Control Group

First Posted Date: 2005-05-03

Last Posted Date: 2010-01-15

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 310

Registration Number: NCT00109720

Locations: 🇺🇸
University of Michigan, Department of Family Medicine Clinics, Ann Arbor, Michigan, United States
🇺🇸
Detroit Health Department, Detroit, Michigan, United States

Vermont Diabetes Information System

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Other: Information and decision support for providers and patients

First Posted Date: 2005-04-27

Last Posted Date: 2011-02-01

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 7500

Registration Number: NCT00109369

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Phase 2

Completed

Conditions: Melanoma

Interventions: Drug: Revlimid

First Posted Date: 2005-04-22

Last Posted Date: 2017-01-02

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 17

Registration Number: NCT00109005

Locations: 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States

Improving Diabetes in Primary Care (IMPACT)

Completed

Conditions: Diabetes Mellitus
Type 2 Diabetes Mellitus
Hypertension

First Posted Date: 2005-04-21

Last Posted Date: 2010-03-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 6000

Registration Number: NCT00108927

Locations: 🇺🇸
Dept of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, United States

The Medical College of Georgia PLAY Project: Exercise Dose and Insulin Sensitivity in Obese Children

Phase 2

Completed

Conditions: Obesity
Type 2 Diabetes Prevention
Executive Function (Cognition)

Interventions: Behavioral: Aerobic exercise program

First Posted Date: 2005-04-21

Last Posted Date: 2014-12-24

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 222

Registration Number: NCT00108901

Locations: 🇺🇸
Georgia Prevention Institute, Medical College of Georgia, Augusta, Georgia, United States

Factors Affecting Caloric Regulation in Human Feeding

Not Applicable

Completed

Conditions: Obesity

First Posted Date: 2005-04-19

Last Posted Date: 2010-01-13

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 100

Registration Number: NCT00108784

Locations: 🇺🇸
General Clinical Research Center: Penn State University, State College, Pennsylvania, United States

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Phase 2

Completed

Conditions: Stage III Prostate Cancer
Recurrent Prostate Carcinoma
Stage IIB Prostate Cancer
Stage IIA Prostate Cancer
Stage I Prostate Cancer

Interventions: Drug: Bicalutamide
Drug: Goserelin Acetate
Biological: Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Biological: Recombinant Vaccinia-TRICOM Vaccine
Biological: Sargramostim

First Posted Date: 2005-04-19

Last Posted Date: 2015-06-30

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 50

Registration Number: NCT00108732

Locations: 🇺🇸
Baptist Cancer Institute, Jacksonville, Florida, United States
🇺🇸
Eastern Cooperative Oncology Group, Boston, Massachusetts, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

and more 4 locations

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Phase 2

Completed

Conditions: Glioma

Interventions: Drug: Tamoxifen citrate
Drug: Bortezomib

First Posted Date: 2005-04-13

Last Posted Date: 2015-11-05

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 43

Registration Number: NCT00108069

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Enzastaurin to Treat Recurrent Brain Tumor

Phase 1

Terminated

Conditions: Glioma

First Posted Date: 2005-04-13

Last Posted Date: 2019-12-05

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 26

Registration Number: NCT00108056

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy